Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:958 (10 November), doi:10.1136/bmj.39388.660174.DB
Roger Dobson
Abergavenny
| The first 150 words of the full text of this article appear below. |
A new information booklet for patients has been produced that emphasises the advantages of taking part in clinical trials and the safety precautions that are taken.
Launched by the UK Clinical Research Collaboration, the booklet—together with an accompanying leaflet—also recommends the questions to which patients should seek answers when considering taking part in trials, and it describes the label "guinea pig" as misleading.
"Clinical trials are the best way to compare different approaches to preventing and treating illness and health problems. Without trials, there is a risk that people could be given treatments which have no advantage, waste resources and might even be harmful," says the booklet, Understanding Clinical Trials.
The companion information leaflet, Clinical Trials: What They Are and What They're Not, emphasises the need for trials and that they should be safe.
In a reference to a clinical trial of an anti-inflammatory drug that led to
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.